SEngine Precision Medicine Presents Innovative Data on the CLIA Certified PARIS® Test for Oncology Drug Sensitivity and the Future of Functional Precision Medicine at AACR 2020

NEXT STORY
BriaCell Announces Presentation of Clinical and Scientific Findings at AACR Annual Meeting
PREV STORY
Preclinical Data from Assembly Biosciences’ Immuno-Oncology Microbiome Program Featured at AACR’s Virtual Annual Meeting II
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Oncternal Therapeutics Announces Closing of $86.2 Million Bought Deal and Full Exercise of Option to Purchase Additional Shares

author_avatar
NASDAQ Market News

Coronavirus Disease 2019 (COVID-19) Impact on the Sales of Immunology Drugs

author_avatar
NASDAQ Market News

Recro Pharma to Participate in Hospital Drug Launch Panel at the JMP Life Sciences Conference

MALVERN, Pa., June 16, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue ...

author_avatar
NASDAQ Market News